Found 7 matching trials
Hormone Therapy in Treating Women With Breast Cancer PHASE2 RATIONALE: Estrogen can stimulate the growth of breast cancer cells. Hormon...
Show More Location
Memorial Sloan-Kettering Cancer Center
Learn More & Join Trial
Tamoxifen Compared With LY353381 in Treating Women With Newly Diagnosed Breast Cancer PHASE1 RATIONALE: Estrogen can stimulate the growth of breast cancer cells. Hormon...
Show More Location
University of Alabama at Birmingham Comprehensive Cancer Center
Learn More & Join Trial
Study Comparing Arzoxifene With Raloxifene in Women After Menopause With Osteoporosis PHASE3 The purpose of this study is to compare the effect of arzoxifene to raloxif...
Show More Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Learn More & Join Trial
Hormone Therapy With Arzoxifene Hydrochloride in Treating Women With Metastatic Refractory Ovarian Cancer or Primary Peritoneal Cancer PHASE2 RATIONALE: Estrogen can stimulate the growth of ovarian cancer cells. Hormo...
Show More Location
Ellis Fischel Cancer Center - Columbia
Learn More & Join Trial
LY353381 in Preventing Breast Cancer in Women With Hyperplasia PHASE2 RATIONALE: Chemoprevention therapy is the use of certain drugs to try to pr...
Show More Location
University of Kansas Medical Center
Learn More & Join Trial
Arzoxifene or Tamoxifen in Preventing Breast Cancer in Premenopausal Women at High Risk for Breast Cancer PHASE2 RATIONALE: Chemoprevention is the use of certain drugs to keep cancer from ...
Show More Location
Multiple Locations
Learn More & Join Trial
Hormone Therapy With Arzoxifene Hydrochloride in Treating Women With Recurrent, Advanced, or Metastatic Endometrial Cancer PHASE2 RATIONALE: Estrogen can stimulate the growth of endometrial cancer cells. H...
Show More Location
Huntington Memorial Hospital
Learn More & Join Trial